News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Potential of iNKT cells to combat resistance to immune checkpoint inhibitors – MiNK Therapeutics
Photo taken from MiNK Therapeutics/LinkedIn
Feb 6, 2024, 14:34

Potential of iNKT cells to combat resistance to immune checkpoint inhibitors – MiNK Therapeutics

Quoting MiNK Therapeutics on LinkedIn:

“New publication in Oncogene spotlights a compelling case study of a durable response to our investigational iNKT cell therapy, agenT-797 in PD-1 refractory gastric cancer: ‘Overcoming Resistance to Programmed Cell Death Protein 1 (PD-1) Blockade with Allogeneic Invariant Natural Killer T-Cells (iNKT)’.

Read more about this case and the potential of iNKT cells to combat resistance to immune checkpoint inhibitors.

Thank you, Benedito A. Carneiro, MD, MS, and Matthew Hadfield, DO, for your collaboration on this important work.”

Source: MiNK Therapeutics/LinkedIn

Benedito A. Carneiro cancer gastric cancer iNKT cell therapy Matthew Hadfield MiNK Therapeutics OncoDaily oncogene Oncology
Special Coverage
Opinion
Apr 16, 2025, 19:46
President of the Oncology Nursing Society opened the 50th Annual ONS Congress - Sylvester Comprehensive Cancer Center
Blog
Apr 16, 2025, 19:26
Laura Moliner: Don’t miss this must-see webinar on Liquid Biopsy in Lung Cancer
Blog
Apr 16, 2025, 19:01
Richard Sullivan: WHO Meeting Reflected on Cancer and IO Drug Pairs
Blog
Apr 16, 2025, 18:50
Join the Third Annual Virtual TAPUR Study Grand Rounds 2025 - ASCO
Blog
Apr 16, 2025, 18:44
The month of the Explore Your Health festival is coming to an end - IARC/WHO
Blog
Apr 16, 2025, 18:38
Why doesn't your body attack the food you eat? - Cancer Research Institute
Blog
Apr 16, 2025, 18:33
Massive Bio has officially received certification from the CNIL
Blog
Apr 16, 2025, 18:17
Peter Pisters: It was wonderful to drop by MD Anderson Cancer Center’s LEADing Leaders/LEADing Institution Training
Blog
Apr 16, 2025, 18:15
MASCC Guidance on Osteoradionecrosis in Patients with Head and Neck Cancer
Blog
Apr 16, 2025, 17:56
Study MSc Transformative Oncology from The University of Manchester online and part-time
Blog
Apr 16, 2025, 17:55
Amol Akhade: Should CDK4/6 inhibitors be standard in early HR+/HER2– breast cancer?
Blog
Apr 16, 2025, 17:46
Dégi László Csaba called for action on QoL in cancer care at EUonQol General Assembly - European Cancer Organisation